Corrigendum to “BRG1 alleviates microglial activation by promoting the KEAP1-NRF2/HO-1 signaling pathway and minimizing oxidative damage in cerebral ischemia–reperfusion” [Int. Immunopharmacol. 119 (2023) 110201]
- Resource Type
- Erratum
- Source
- In
International Immunopharmacology 10 March 2024 129 - Subject
- Language
- ISSN
- 1567-5769